About the Cardiovascular CAG
Across the partnership our CAG offers expertise of clinical and laboratory research in cardiac pathophysiology, vascular pathology, epigenetics and clinical human pathophysiology. Currently our organisations have close, functioning collaborations with several departments in the Trusts and University, namely, Anesthetics & Intensive Care Medicine at Royal Surrey County Hospital NHS Foundation Trust and at Ashford and St Peter’s Hospitals NHS Foundation Trust; MATTU; and the Faculty of Health and Medical Sciences; Biomedical engineering unit and Advanced Technology Institute at University of Surrey. This Unit is also generating new links at our Trust hospitals, including endocrinology and general surgery.
The Cardiovascular CAG membership has active collaborations with external units including: Cardiothoracic Surgery at St George’s Hospital; Cardiology at Papworth Hospital; the NHLI at Hammersmith Hospital, Imperial College, Dept of Medicine at University of Pittsburgh and Dept Cardiology at Georgetown University.
The membership also has several collaborations and associations with external bodies concerned with medical training; including The Royal College of Physicians, Surgeons, O&G and Anaesthetics. This includes; development of training paradigms, examining at entry and exit specialty levels and intermediate training in specialist areas associated with cardiology.
The Cardiovascular CAG’s 3-5 year vision is to:
• Develop a world-class clinical research portfolio through integration of resources and expertise not only within the current existing CAG, but also through collaboration with other CAGs and multidisciplinary teams not belonging to any specific CAGs.
•Provide a comprehensive undergraduate and postgraduate teaching programme in cardiovascular medicine open both nationally and internationally.
•Implement a programme of innovation to enhance service delivery across all aspects of cardiac services.
•Provide sub-speciality training in clinical cardiology through a programme of cooperation and collaboration between RSCH and ASPH.
•Lead on the provision of joint clinical/academic posts that underpin a specific and strategic research portfolio.
The Director of the Institute is Professor Pankaj Sharma. In addition to being its director he is also a consultant neurologist at Imperial College Healthcare NHS Trust.
Professor Sharma holds a University of London Chair of Neurology at Royal Holloway. He is a former British Heart Foundation Clinician Scientist at Cambridge and a Fulbright Scholar at Harvard Medical School. He holds double doctorates from both the University of Cambridge and University of London. Most recently he led the internationally renowned Imperial College Cerebrovascular Research Unit at Imperial College London.
Professor Sharma’s research seeks to use genetics, genomics and proteomics to advance human understanding of cerebrovascular disease in three key areas: prediction, diagnosis and treatment of stroke at the molecular level. He has a particular interest in the genetics of stroke in ethnic minorities, particularly South Asians and Middle Eastern populations.
He holds doctorates from the universities of London (MD) and Cambridge (PhD).
Professor Christopher Fry chairs the Institute and works with a steering group to map strategy. He is also chair of Applied Physiology in the School of Physiology, Pharmacology & Neuroscience at the University of Bristol.
Chris has held past posts at St Thomas’ Hospital, University College London and Surrey University and retains strong research collaborations with Surrey. His research interests centre around disorders of excitation-contraction in the heart and visceral smooth muscle and their relation to organ pathologies. He also has an interest in optimising cardiovascular system function in patients undergoing major surgery, as part of the enhanced recovery programme.
Our Principal Investigators are:
For a comprehensive review of our Principal Investigator research interests click here